Functional Importance of Hydrophobic Patches on the Ebola Virus VP35 IFN-Inhibitory Domain

Functional Importance of Hydrophobic Patches on the Ebola Virus VP35 IFN-Inhibitory Domain

Viral protein 35 (VP35) of Ebola virus (EBOV) is a multifunctional protein that mainly acts as a viral polymerase cofactor and an interferon antagonist. VP35 interacts with the viral nucleoprotein (NP) and double-stranded RNA for viral RNA transcription/replication and inhibition of type I interfero...

Full description

Bibliographic Details
Main Authors:	Nodoka Kasajima, Keita Matsuno, Hiroko Miyamoto, Masahiro Kajihara, Manabu Igarashi, Ayato Takada
Format:	Article
Language:	English
Published:	MDPI AG 2021-11-01
Series:	Viruses
Subjects:	Ebola virus VP35 polymerase cofactor interferon antagonist IFN-inhibitory domain hydrophobic patch
Online Access:	https://www.mdpi.com/1999-4915/13/11/2316

Similar Items

Computational Study on Potential Novel Anti-Ebola Virus Protein VP35 Natural Compounds
by: Louis K. S. Darko, et al.
Published: (2021-11-01)

Development and Validation of a Novel Dual Luciferase Reporter Gene Assay to Quantify Ebola Virus VP24 Inhibition of IFN Signaling
by: Elisa Fanunza, et al.
Published: (2018-02-01)

Ebola virus sequesters IRF3 in viral inclusion bodies to evade host antiviral immunity
by: Lin Zhu, et al.
Published: (2024-01-01)

Evasion of the Interferon-Mediated Antiviral Response by Filoviruses
by: Washington B. Cárdenas
Published: (2010-01-01)

Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction
by: Michelle L. Pleet, et al.
Published: (2016-11-01)

Cheminformatics-Based Study Identifies Potential Ebola VP40 Inhibitors
by: Emmanuel Broni, et al.
Published: (2023-03-01)

Corrigendum: Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction
by: Michelle L. Pleet, et al.
Published: (2018-04-01)

Novel Antiviral Molecules against Ebola Virus Infection
by: Mila Collados Rodríguez, et al.
Published: (2023-09-01)

The Minor Matrix Protein VP24 from Ebola Virus Lacks Direct Lipid-Binding Properties
by: Yuan Su, et al.
Published: (2020-08-01)

Evaluation of fendiline treatment in VP40 system with nucleation-elongation process: a computational model of Ebola virus matrix protein assembly
by: Xiao Liu, et al.
Published: (2024-04-01)

The Ebola Virus Interferon Antagonist VP24 Undergoes Active Nucleocytoplasmic Trafficking
by: Angela R. Harrison, et al.
Published: (2021-08-01)

Ebola-Detect: A differential serodiagnostic assay for Ebola virus infections and surveillance in the presence of vaccine-induced antibodies
by: Supriya Ravichandran, et al.
Published: (2022-08-01)

Cellular mRNA triggers structural transformation of Ebola virus matrix protein VP40 to its essential regulatory form
by: Sara Landeras-Bueno, et al.
Published: (2021-04-01)

A Loop Region in the N-Terminal Domain of Ebola Virus VP40 Is Important in Viral Assembly, Budding, and Egress
by: Emmanuel Adu-Gyamfi, et al.
Published: (2014-10-01)

Serine-Arginine Protein Kinase 1 Regulates Ebola Virus Transcription
by: Yuki Takamatsu, et al.
Published: (2020-02-01)

Human Parainfluenza Virus 3 Phosphoprotein Is a Tetramer and Shares Structural and Interaction Features with Ebola Phosphoprotein VP35
by: Joaquin Rodriguez Galvan, et al.
Published: (2021-10-01)

Ubiquitin Ligase SMURF2 Interacts with Filovirus VP40 and Promotes Egress of VP40 VLPs
by: Ariel Shepley-McTaggart, et al.
Published: (2021-02-01)

Molecular docking study of anti-viral FDA-approved drugs as novel entry and replication Ebola viral inhibitors
by: Saghi Sepehri, et al.
Published: (2019-04-01)

Alphavirus Replicon DNA Vectors Expressing Ebola GP and VP40 Antigens Induce Humoral and Cellular Immune Responses in Mice
by: Shoufeng Ren, et al.
Published: (2018-01-01)

Putative endogenous filovirus VP35-like protein potentially functions as an IFN antagonist but not a polymerase cofactor.
by: Tatsunari Kondoh, et al.
Published: (2017-01-01)

Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion
by: Michelle L. Pleet, et al.
Published: (2019-05-01)

Development of Monoclonal Antibody to Specifically Recognize VP0 but Not VP4 and VP2 of Foot-and-Mouth Disease Virus
by: Sun Young Park, et al.
Published: (2022-12-01)

Strain-Specific Interactions between the Viral Capsid Proteins VP4, VP7 and VP6 Influence Rescue of Rotavirus Reassortants by Reverse Genetics
by: Roman Valusenko-Mehrkens, et al.
Published: (2023-03-01)

Frontal VP & VA Shunts Versus post parietal VP &VA Shunts
by: A- Hadi Khalili, et al.
Published: (2005-04-01)

Host factor SMYD3 is recruited by Ebola virus nucleoprotein to facilitate viral mRNA transcription
by: Jingliang Chen, et al.
Published: (2019-01-01)

Cytokine gene polymorphisms of TNF, IFN-γ, and IL-12 as potential predictors in the onset of cervical disease in HR HPV-positive women with behavioral risk cofactors
by: Tasić-Tomić Dijana, et al.
Published: (2022-01-01)

Structural and Dynamical Basis of VP35-RBD Inhibition by Marine Fungi Compounds to Combat Marburg Virus Infection
by: Abdullah S. Alawam, et al.
Published: (2024-01-01)

Ébola (Enfermedad por el Virus del Ébola
by: Cristina Fernández Barrantes
Published: (2014-11-01)

The Stronger Downregulation of in vitro and in vivo Innate Antiviral Responses by a Very Virulent Strain of Infectious Bursal Disease Virus (IBDV), Compared to a Classical Strain, Is Mediated, in Part, by the VP4 Protein
by: Katherine L. Dulwich, et al.
Published: (2020-06-01)

Host and Viral Proteins Modulating Ebola and Marburg Virus Egress
by: Tamsin B. Gordon, et al.
Published: (2019-01-01)

V.P. Zinchenko Through the Lens of His Relations (Based on V.P. Zinochenko’s Autobiographical Materials
by: Meshcheryakov B.G.
Published: (2021-11-01)

Ebola and Marburg virus matrix layers are locally ordered assemblies of VP40 dimers
by: William Wan, et al.
Published: (2020-10-01)

The Boundaries of Treating Ebola
by: Dallas Ducar
Published: (2014-08-01)

Ethicizing the Ebola Epidemic
by: Louisa Howard
Published: (2014-10-01)

Cheminformatics Strategies Unlock Marburg Virus VP35 Inhibitors from Natural Compound Library
by: Isra M. Alsaady, et al.
Published: (2023-08-01)

Foot-and-Mouth Virus Capsid Protein VP1 Antagonizes Type I Interferon Signaling via Degradation of Histone Deacetylase 5
by: Qing Gong, et al.
Published: (2024-03-01)

In-silico identification of novel natural drug leads against the Ebola virus VP40 protein: A promising approach for developing new antiviral therapeutics
by: Noimul Hasan Siddiquee, et al.
Published: (2024-01-01)

Ebola: Working Through Fear
by: Brenda Fitzgerald
Published: (2015-04-01)

Generation and Characterization of a Mouse-Adapted Makona Variant of Ebola Virus
by: Mable Chan, et al.
Published: (2019-10-01)

Symptom-Based Ebola Risk Score for Ebola Virus Disease, Conakry, Guinea
by: Brecht Ingelbeen, et al.
Published: (2018-06-01)